Riju Ray, MD, PhD

GlaxoSmithKline
Durham, NC, United States

MD, PhD in early clinical research in Pharma.

Presentation(s):

• 0309: Efficacy, Safety, Pharmacokinetics and Immunogenicity of Repeated Dosing of GSK3858279 in Patients with Knee Osteoarthritis: A Phase I, Randomized, Double-Blind, Placebo-Controlled Study

  Sunday, November 12, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.